Probiotics and Intestinal Infections in Preschool Children
Overview of Gastroenteritis
The New England Journal of Medicine recently published a study exploring the effects of probiotics on intestinal infections, specifically in preschool-aged children. Acute gastroenteritis, a common intestinal infection, remains one of the leading causes of mortality in children within underdeveloped nations. While it is less lethal in many developed countries today, it continues to place a significant strain on global healthcare systems.
Treatment Approaches for Gastroenteritis
Current treatment strategies for gastroenteritis focus on symptom management, dehydration prevention, and avoiding further complications or infections in close contacts. Various medications are utilized, particularly for infectious diarrhea, including those aimed at symptom control and different classes of antibiotics prescribed for infectious causes.
Limitations of Previous Probiotic Studies
Prior research has indicated that probiotics may alleviate symptoms of gastroenteritis in children; however, these studies have faced several limitations that undermine the strength of their recommendations. Key issues include small participant sizes, variability in the quality of probiotics used, and challenges in establishing clear causality. Furthermore, there is a scarcity of studies analyzing the effects of probiotics in outpatient pediatric care.
Rising Popularity of Probiotics
Despite the limited high-quality evidence supporting the efficacy of probiotics for treating gastroenteritis in children, the global market for probiotics continues to expand.
Recent Clinical Trial Findings
A randomized clinical trial, as detailed in the New England Journal of Medicine, investigated the role of probiotics in children suffering from acute gastroenteritis. Conducted in the United States, the study involved 971 children aged between three months and four years who were treated at one of ten pediatric emergency departments. Participants were randomly assigned to receive either a five-day course of the probiotic Lactobacillus rhamnosus, administered twice daily, or a matching placebo.
Results and Conclusions
Follow-up assessments were conducted over a 30-day period. The findings revealed no significant differences in the duration of diarrhea, vomiting, or daycare absenteeism between the group receiving probiotics and the placebo group. The authors concluded that in preschool children with acute gastroenteritis, probiotics did not demonstrate greater efficacy than a placebo.
Reference
Schnadower, D., Tarr, P. I., Casper, T. C., Gorelick, M. H., Dean, J. M., O’Connell, K. J., … & Powell, E. C. (2018). Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. New England Journal of Medicine, 379(21), 2002-2014.